ALFA Finder| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 44.5 | 115.2 | 32.4 |
| Other income | 0.1 | 0.0 | 0.1 |
| Total income | 44.5 | 115.2 | 32.6 |
| Profit before exceptional items & tax | 1.2 | 1.8 | 1.0 |
| Profit before tax | 1.2 | 1.8 | 1.0 |
| Net profit | 0.9 | 1.4 | 0.7 |
| Operating margin | 2.7% | 1.6% | 3.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +28.60% |
|---|---|
| Net profit, quarter on quarter | -35.70% |
| Revenue, year on year | +37.30% |
| Operating profit, year on year | +22.20% |
| Operating profit, quarter on quarter | -38.90% |
BSE results filing, NSE: MKPL. Figures extracted from the filing.
M K Proteins Ltd: key numbers
- Share price
- ₹3.85
- Market cap
- ₹144.5 Cr
- Revenue (annual)
- ₹382.9 Cr
- Net profit (annual)
- ₹6.83 Cr
- P/E (TTM)
- 30.0×Sector 40.6×
- Promoter holding
- 74.82%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from M K Proteins Ltd
All →M K Proteins Board Meeting Date
M K Proteins will hold a board meeting on 13 November 2026 to consider unaudited half-yearly results. The trading window stays closed until 15 November 2026.
M K Proteins Other Announcement
Standard quarterly shareholding pattern filing for M. K. Proteins Ltd for the quarter ended September 30, 2026.
M K Proteins Management Change
M. K. Proteins Ltd's shareholders approved the appointment of Ms. Aritika Garg as an Independent Director for a five-year term at the 14th AGM.
M K Proteins Annual General Meeting
M. K. Proteins Limited conducted its 14th Annual General Meeting on September 30, 2026. Shareholders considered financial statements, director appointments, and related party transaction approvals.
M K Proteins Other Announcement
M K Proteins Limited is providing the Annual Report for FY 2025-26 to shareholders via web links and QR codes, per Regulation 36(1)(b) of SEBI LODR.
M K Proteins Annual General Meeting
M K Proteins Limited has scheduled its 14th Annual General Meeting for September 30, 2026, and approved the associated notice and directors' report.